Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy

Dhanesh Amarnani1, Arturo Israel Machuca-Parra1, Lindsay L Wong1

  • 1Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States.

Abstract

Insights

Researchers developed a method to culture cells from proliferative vitreoretinopathy (PVR) membranes for drug testing. Methotrexate (MTX) was found to reduce PVR cell growth and induce cell death in these cultures.

Area of Science:

  • Ophthalmology and cell biology.
  • Investigating cellular mechanisms in retinal diseases.

Background:

  • Proliferative vitreoretinopathy (PVR) is a severe complication of retinal detachment.
  • Current drug testing methods for PVR lack patient-specific cellular models.

Purpose of the Study:

  • To establish a reliable method for isolating and culturing cells from patient-derived PVR membranes.
  • To create an in vitro model for drug screening and testing against PVR.

Main Methods:

  • PVR membranes from Grade C patients were obtained and processed.
  • Cells were isolated, cultured, and characterized using immunohistochemistry.
  • The effects of methotrexate (MTX) on cell proliferation, migration, and death were evaluated.

Main Results:

  • Successful isolation and culture of primary PVR cells (C-PVR) exhibiting characteristic markers.
  • C-PVR cultures formed membrane and band-like structures in vitro.
  • Methotrexate significantly inhibited C-PVR proliferation and band formation while inducing cell death.

Conclusions:

  • Patient-derived PVR cells can be effectively isolated, cultured, and profiled in vitro.
  • This novel cell culture system provides a valuable platform for PVR drug discovery.
  • Methotrexate demonstrates potential as a therapeutic agent by reducing PVR cell growth and inducing apoptosis.

Related Concept Videos